FI
IMGN

Fosun International’s Immunogen Inc IMGN Stock Holding History

Fosun International’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-248,749
Closed -$1.11M – 334
2018
Q4 		$1.11M Buy
248,749
+70,000
+39% +$425K 0.07% 126
2018
Q3 		$1.72M Buy
+178,749
New +$1.72M 0.08% 103

Other funds holding IMGN

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fosun International's IMGN Position: Q1 2019 in Review

Fosun International sold out of Immunogen Inc (IMGN) in Q1 2019, closing a stake of 248,749 shares — an estimated $1.11M sold.

Fosun International first reported a position in IMGN in Q3 2018 and held it in 2 quarters. The position peaked at $1.72M in Q3 2018. 212 funds tracked by Wall St. Rank hold IMGN as of Q1 2019.

  • Fosun International reported no remaining Immunogen Inc position as of Q1 2019 after selling out during the quarter.
  • Fosun International sold 248,749 Immunogen Inc shares in Q1 2019, an estimated $1.11M.
  • Fosun International first reported a position in Immunogen Inc in Q3 2018 and held it in 2 quarters.
  • Fosun International's Immunogen Inc position peaked at $1.72M in Q3 2018.
  • 212 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2019.

Based on Fosun International's 13F filing for Q1 2019, filed 10 May 2019.